Flputnam Investment Management Co. purchased a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 14,389 shares of the conglomerate's stock, valued at approximately $2,741,000.
Other institutional investors have also recently added to or reduced their stakes in the company. Sivia Capital Partners LLC raised its stake in shares of Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate's stock worth $397,000 after buying an additional 119 shares during the last quarter. First Trust Advisors LP increased its position in Danaher by 34.5% during the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate's stock worth $10,947,000 after buying an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC raised its holdings in shares of Danaher by 40.2% in the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate's stock worth $610,000 after acquiring an additional 886 shares during the last quarter. Ieq Capital LLC raised its stake in Danaher by 64.2% in the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate's stock valued at $14,957,000 after purchasing an additional 29,592 shares during the last quarter. Finally, HUB Investment Partners LLC raised its stake in Danaher by 30.7% in the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate's stock valued at $273,000 after purchasing an additional 325 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.
Danaher Trading Up 0.0%
NYSE:DHR opened at $202.51 on Monday. The business's 50-day moving average is $193.14 and its two-hundred day moving average is $192.91. The firm has a market capitalization of $142.37 billion, a PE ratio of 35.97, a price-to-earnings-growth ratio of 2.52 and a beta of 0.78. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.
Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company's revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter last year, the firm earned $0.77 earnings per share. Research analysts predict that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.
Analysts Set New Price Targets
DHR has been the topic of a number of analyst reports. UBS Group decreased their target price on shares of Danaher from $270.00 to $250.00 and set a "buy" rating on the stock in a research report on Wednesday, April 22nd. Royal Bank Of Canada increased their target price on Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 22nd. Wall Street Zen downgraded shares of Danaher from a "buy" rating to a "hold" rating in a research note on Saturday, April 25th. Weiss Ratings upgraded shares of Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, July 15th. Finally, Guggenheim dropped their price objective on Danaher from $235.00 to $200.00 and set a "buy" rating for the company in a report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $228.91.
Get Our Latest Stock Analysis on Danaher
Danaher Company Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.